Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Knockout mice reveal a tumor suppressor function for Testin.

Alessandra Drusco1, Nicola Zanesi, Claudia Roldo

  • 1Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.

Proceedings of the National Academy of Sciences of the United States of America
|July 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin.

EBioMedicine·2018
Same author

MicroRNAs and Cancer: A Long Story for Short RNAs.

Advances in cancer research·2017
Same author

Discovery and characterization of the feline miRNAome.

Scientific reports·2017
Same author

Determination of absolute expression profiles using multiplexed miRNA analysis.

PloS one·2017
Same author

tsRNA signatures in cancer.

Proceedings of the National Academy of Sciences of the United States of America·2017
Same author

Extracellular Vesicle Biology in the Pathogenesis of Lung Disease.

American journal of respiratory and critical care medicine·2017

The Testin (TES) gene acts as a tumor suppressor. Loss of TES function in mice significantly increased susceptibility to gastric cancer, confirming its role in preventing tumor development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The Testin (TES) gene is located at 7q31.2, a chromosomal region frequently altered in various cancers.
  • TES is a putative tumor suppressor gene, but its in vivo function remains unconfirmed.

Purpose of the Study:

  • To investigate the in vivo tumor suppressor role of the Testin (TES) gene.
  • To evaluate the impact of TES gene deficiency on carcinogen-induced gastric cancer development.

Main Methods:

  • Generated Tes knockout mice (wild-type, heterozygous, homozygous).
  • Utilized a N-nitrosomethylbenzylamine (NMBA)-induced gastric cancer model in mice.
  • Administered zinc-deficient (ZD) or zinc-sufficient (ZS) diets and NMBA treatment.

Related Experiment Videos

Main Results:

  • Tes heterozygous (+/-) mice showed an 88% tumor incidence with various lesions.
  • Tes homozygous (-/-) mice exhibited an 81% incidence of aggressive tumors, including adenocarcinomas.
  • Tumor incidence was significantly higher in TES-deficient mice compared to wild-type (+/+) controls (P < 0.0001).

Conclusions:

  • The Testin (TES) gene functions as a tumor suppressor in vivo.
  • Loss of TES significantly enhances susceptibility to gastric carcinogenesis.
  • TES deficiency contributes to the development of malignant tumors in the forestomach.